Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Neurotherapeutics
Metadata
Title
Biomarkers and surrogate markers: An FDA perspective
Author
Russell Katz
Publication date
01-04-2004
Publisher
Springer-Verlag
Published in
Neurotherapeutics / Issue 2/2004
Print ISSN: 1933-7213
Electronic ISSN: 1878-7479
DOI
https://doi.org/10.1602/neurorx.1.2.189

Other articles of this Issue 2/2004

Neurotherapeutics 2/2004 Go to the issue

OriginalPaper

Huntington’s disease genetics

OriginalPaper

Measures and markers in Amyotrophic Lateral Sclerosis

OriginalPaper

Molecular neuroimaging in Alzheimer’s disease

OriginalPaper

Biomarkers: Potential uses and limitations

OriginalPaper

Neuroimaging in Parkinson’s disease

OriginalPaper

Biomarkers of Alzheimer disease in plasma